Cargando...
Population level outcomes and cost‐effectiveness of hepatitis C treatment pre‐ vs postkidney transplantation
Direct‐acting antivirals approved for use in patients with end‐stage renal disease (ESRD) now exist. HCV‐positive (HCV+) ESRD patients have the opportunity to decrease the waiting times for transplantation by accepting HCV‐infected kidneys. The optimal timing for HCV treatment (pre‐ vs posttransplan...
Gardado en:
| Publicado en: | Am J Transplant |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6206868/ https://ncbi.nlm.nih.gov/pubmed/30058218 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajt.15040 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|